Home/Filings/4/0001011034-09-000086
4//SEC Filing

KEMPF DAVID A 4

Accession 0001011034-09-000086

CIK 0001443062other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 12:58 PM ET

Size

13.0 KB

Accession

0001011034-09-000086

Insider Transaction Report

Form 4
Period: 2009-07-01
KEMPF DAVID A
DirectorCOO/CFO
Transactions
  • Award

    common stock

    2009-07-01+2,5005,500 total
Holdings
  • options

    Exercise: $1.00From: 2010-02-11Exp: 2019-02-11common stock (100,000 underlying)
    100,000
  • options

    Exercise: $1.00From: 2012-02-11Exp: 2019-02-11common stock (100,000 underlying)
    300,000
  • Series A Convertible Preferred Stock

    Exercise: $0.75From: 2009-06-17common stock (10,000 underlying)
    316,667
  • options

    Exercise: $1.00From: 2011-02-11Exp: 2019-02-11common stock (100,000 underlying)
    200,000
  • Series A Convertible Preferred Stock

    Exercise: $0.75From: 2009-04-15common stock (6,667 underlying)
    306,667
  • common stock

    (indirect: By IRA)
    3,000
  • warrants

    Exercise: $1.50From: 2009-06-17Exp: 2010-12-17common stock (3,750 underlying)
    320,417
Footnotes (2)
  • [F1]grant of shares valued at $0.51 per share
  • [F2]Not applicable

Issuer

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

CIK 0001443062

Entity typeother

Related Parties

1
  • filerCIK 0001458510

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 12:58 PM ET
Size
13.0 KB